ABUS
Price
$3.88
Change
+$0.09 (+2.37%)
Updated
Oct 11 closing price
25 days until earnings call
AXON
Price
$434.98
Change
+$6.22 (+1.45%)
Updated
Oct 11 closing price
26 days until earnings call
Ad is loading...

ABUS vs AXON

Header iconABUS vs AXON Comparison
Open Charts ABUS vs AXONBanner chart's image
Arbutus Biopharma
Price$3.88
Change+$0.09 (+2.37%)
Volume$443.99K
CapitalizationN/A
Axon Enterprise
Price$434.98
Change+$6.22 (+1.45%)
Volume$334.52K
CapitalizationN/A
View a ticker or compare two or three
ABUS vs AXON Comparison Chart
Loading...
ABUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABUS vs. AXON commentary
Oct 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABUS is a Hold and AXON is a StrongBuy.

COMPARISON
Comparison
Oct 12, 2024
Stock price -- (ABUS: $3.79 vs. AXON: $434.98)
Brand notoriety: ABUS and AXON are both not notable
ABUS represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: ABUS: 55% vs. AXON: 55%
Market capitalization -- ABUS: $723.04M vs. AXON: $29.88B
ABUS [@Biotechnology] is valued at $723.04M. AXON’s [@Aerospace & Defense] market capitalization is $29.88B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $201.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B. The average market capitalization across the [@Aerospace & Defense] industry is $14.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABUS’s FA Score shows that 0 FA rating(s) are green whileAXON’s FA Score has 2 green FA rating(s).

  • ABUS’s FA Score: 0 green, 5 red.
  • AXON’s FA Score: 2 green, 3 red.
According to our system of comparison, AXON is a better buy in the long-term than ABUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABUS’s TA Score shows that 2 TA indicator(s) are bullish while AXON’s TA Score has 4 bullish TA indicator(s).

  • ABUS’s TA Score: 2 bullish, 7 bearish.
  • AXON’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, AXON is a better buy in the short-term than ABUS.

Price Growth

ABUS (@Biotechnology) experienced а -1.56% price change this week, while AXON (@Aerospace & Defense) price change was +3.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +0.65%. For the same industry, the average monthly price growth was +9.56%, and the average quarterly price growth was +7.97%.

Reported Earning Dates

ABUS is expected to report earnings on Feb 27, 2025.

AXON is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+0.65% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($29.9B) has a higher market cap than ABUS($723M). AXON YTD gains are higher at: 68.382 vs. ABUS (51.600). AXON has higher annual earnings (EBITDA): 392M vs. ABUS (-75.48M). AXON has more cash in the bank: 1.08B vs. ABUS (142M). ABUS has less debt than AXON: ABUS (1.6M) vs AXON (720M). AXON has higher revenues than ABUS: AXON (1.81B) vs ABUS (10.1M).
ABUSAXONABUS / AXON
Capitalization723M29.9B2%
EBITDA-75.48M392M-19%
Gain YTD51.60068.38275%
P/E RatioN/A105.41-
Revenue10.1M1.81B1%
Total Cash142M1.08B13%
Total Debt1.6M720M0%
FUNDAMENTALS RATINGS
ABUS vs AXON: Fundamental Ratings
ABUS
AXON
OUTLOOK RATING
1..100
5320
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
91
Overvalued
PROFIT vs RISK RATING
1..100
556
SMR RATING
1..100
9753
PRICE GROWTH RATING
1..100
451
P/E GROWTH RATING
1..100
10087
SEASONALITY SCORE
1..100
7595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABUS's Valuation (64) in the Biotechnology industry is in the same range as AXON (91). This means that ABUS’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (6) in the Biotechnology industry is somewhat better than the same rating for ABUS (55). This means that AXON’s stock grew somewhat faster than ABUS’s over the last 12 months.

AXON's SMR Rating (53) in the Biotechnology industry is somewhat better than the same rating for ABUS (97). This means that AXON’s stock grew somewhat faster than ABUS’s over the last 12 months.

AXON's Price Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for ABUS (45). This means that AXON’s stock grew somewhat faster than ABUS’s over the last 12 months.

AXON's P/E Growth Rating (87) in the Biotechnology industry is in the same range as ABUS (100). This means that AXON’s stock grew similarly to ABUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABUSAXON
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
70%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
55%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Ad is loading...
ABUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X62445.0900002170.586000
+3.60%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

ABUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with ROIV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABUS
1D Price
Change %
ABUS100%
+0.80%
ROIV - ABUS
45%
Loosely correlated
+3.13%
ARRY - ABUS
43%
Loosely correlated
-5.64%
AXON - ABUS
42%
Loosely correlated
-0.78%
VIR - ABUS
40%
Loosely correlated
+0.14%
LRMR - ABUS
40%
Loosely correlated
-3.69%
More